Clinical Controversies in Infectious Diseases

That is the topic of this session and in particular TB

Should We Replace Tuberculin Skin Tests (TSTs) with Interferon Gamma Release Assays (IGRAs)? YES

Given that the date is October should Cellestis shareholders, who are presently being distracted by their own "controversy," care?

YES